Ishita Drugs Re-appoints Director Post 75 Years, Approves Q1 Results

Ishita Drugs & Industries Ltd announced the re-appointment of Mrs. Abha Agrawal as a Non-Executive Non-Independent Director, following her attainment of 75 years of age. The company's Board of Directors also approved the Unaudited Financial Results for the quarter ended June 30, 2026. Additionally, the Board approved amendments to the notice for the 33rd Annual General Meeting and accepted revised remuneration for the CFO. The company is also progressing with its manufacturing facility upgradation project, with significant expenditure incurred and ongoing negotiations for financing.